Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.99
0.12 (6.42%)
At close: Sep 26, 2025, 3:59 PM
1.98
-0.50%
After-hours: Sep 26, 2025, 06:21 PM EDT
Aclaris Therapeutics Revenue
Aclaris Therapeutics reported an annual revenue of $18.72M, reflecting a -40.09% growth. For the quarter ending June 30, 2025, Aclaris Therapeutics generated $1.78M in revenue.
Revenue (ttm)
18.72M
Revenue Growth
-40.09%
Price / Sales Ratio
10.24
Revenue / Employee
306.89K
Employees
61
Market Cap
215.58M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 18.72M | -40.09% |
| Dec 31, 2023 | 31.25M | +5.03% |
| Dec 31, 2022 | 29.75M | +340.05% |
| Dec 31, 2021 | 6.76M | +4.30% |
| Dec 31, 2020 | 6.48M | +53.35% |
| Dec 31, 2019 | 4.23M | -58.11% |
| Dec 31, 2018 | 10.09M | +499.58% |
| Dec 31, 2017 | 1.68M | +Infinity% |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |